Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.411NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.217NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.527NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.500NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.121NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AS.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.115NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.127.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.88NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.185NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.329NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.229NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.342NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.90NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.169NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.528NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.175NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.483NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.181NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.113NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.594NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.328NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.145NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.547NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.247NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.205NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.110NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.434NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.181NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used